1. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 2-2
&NA;,
Preview
|
PDF (1119KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
2. |
Pig organ transplants: overcoming hyperacute rejection |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 3-4
Sandra MacPherson,
Preview
|
PDF (2096KB)
|
|
摘要:
Sometime this year a human being is likely to receive a replacement organ from a pig genetically engineered for this purpose. It will not be the first time that animal organs have been used in an attempt to prolong human life. The first xenotransplantation procedures were conducted as early as 1964. So far, none can be considered successful - most recipients died within days, or even hours. The key problem is hyperacute rejection. This highly aggressive immune response can destroy the transplanted organ completely within minutes, and it cannot be controlled by immunosuppressive drugs. However, progress has been made. In this article,Inpharma® looks at research that has led to successful pig-to-monkey transplantations, and examines the implications of this research for future transplantation practice in humans.
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
3. |
Management of MI patients: still room for improvement |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 4-4
&NA;,
Preview
|
PDF (1072KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
4. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 5-5
&NA;,
Preview
|
PDF (1031KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
5. |
Benefits of simvastatin offset 88% of drug's cost - 4S data |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 6-6
&NA;,
Preview
|
PDF (1029KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
6. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 7-7
&NA;,
Preview
|
PDF (992KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
7. |
Dolasetron as effective at preventing nausea and vomiting as granisetron |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 8-8
&NA;,
Preview
|
PDF (1018KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
8. |
Latest news on treatments in R&D for Parkinson's disease |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 9-10
Gill Higgins,
Preview
|
PDF (2294KB)
|
|
摘要:
More than 30 drugs are being evaluated in clinical trials for their therapeutic potential in Parkinson's disease. Of these, at least 10 are in phase III testing or are awaiting registration. Among the benefits offered by these new drugs is the ability to delay the need for levodopa therapy. In this respect, the new agents may provide serious competition to Pharmacia & Upjohn's dopamine agonist cabergoline, which was approved for the treatment of Parkinson's disease earlier this year. New data on ropinirole, another dopamine agonist cabergoline, which was approved for the treatment of Parkinson's disease earlier this year. New data on ropinirole, another dopamine agonist, and several other agents in research and development were presented at the 4th International Congress of Movement Disorders [Vienna, Austria; June 1996].
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
9. |
E-5166 (polyprenoic acid) reduces rate of second primary HCC |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 10-10
&NA;,
Preview
|
PDF (1105KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|
10. |
News in brief … |
|
Inpharma Weekly,
Volume &NA;,
Issue 1042,
1996,
Page 11-11
&NA;,
Preview
|
PDF (832KB)
|
|
ISSN:1173-8324
出版商:ADIS
年代:1996
数据来源: ADIS
|